Clinical Antibiotic-resistant Acinetobacter baumannii Strains with Higher Susceptibility to Environmental Phages than Antibiotic-sensitive Strains
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Antibiotic-resistant Acinetobacter baumannii Strains with Higher Susceptibility to Environmental Phages than Antibiotic-sensitive Strains
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-07-18
DOI
10.1038/s41598-017-06688-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural basis for fragmenting the exopolysaccharide of Acinetobacter baumannii by bacteriophage ΦAB6 tailspike protein
- (2017) I-Ming Lee et al. Scientific Reports
- Characterization and complete genome sequence analysis of twoMyoviralbacteriophages infecting clinical carbapenem-resistantAcinetobacter baumanniiisolates
- (2016) J. Jeon et al. JOURNAL OF APPLIED MICROBIOLOGY
- Analysis of tigecycline resistance development in clinical Acinetobacter baumannii isolates through a combined genomic and transcriptomic approach
- (2016) Lin Liu et al. Scientific Reports
- Antimicrobial susceptibility among important pathogens collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) in Spain, 2004–2014
- (2016) Francesc Marco et al. Journal of Global Antimicrobial Resistance
- The Tail Associated Protein of Acinetobacter baumannii Phage ΦAB6 Is the Host Specificity Determinant Possessing Exopolysaccharide Depolymerase Activity
- (2016) Meng-Jiun Lai et al. PLoS One
- Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
- (2016) Benjamin K. Chan et al. Scientific Reports
- Imipenem represses CRISPR-Cas interference of DNA acquisition through H-NS stimulation in Klebsiella pneumoniae
- (2016) Tzu-Lung Lin et al. Scientific Reports
- Antibiotic Modulation of Capsular Exopolysaccharide and Virulence in Acinetobacter baumannii
- (2015) Edward Geisinger et al. PLoS Pathogens
- Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates
- (2014) Fan Peng et al. BMC MICROBIOLOGY
- Exposure to phages has little impact on the evolution of bacterial antibiotic resistance on drug concentration gradients
- (2014) Quan-Guo Zhang Evolutionary Applications
- Rapid identification of Acinetobacter baumannii, Acinetobacter nosocomialis and Acinetobacter pittii with a multiplex PCR assay
- (2014) T.-L. Chen et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Contrasted coevolutionary dynamics between a bacterial pathogen and its bacteriophages
- (2014) A. Betts et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antimicrobial resistance inAcinetobacter baumannii: From bench to bedside
- (2014) Ming-Feng Lin World Journal of Clinical Cases
- Potential of bacteriophage ΦAB2 as an environmental biocontrol agent for the control of multidrug-resistant Acinetobacter baumannii
- (2013) Li-Kuang Chen et al. BMC MICROBIOLOGY
- Identification and characterisation of the putative phage-related endolysins through full genome sequence analysis in Acinetobacter baumannii ATCC 17978
- (2013) Meng-Jiun Lai et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria
- (2013) Elizabeth MH Wellington et al. LANCET INFECTIOUS DISEASES
- The Rise of Carbapenem-Resistant Acinetobacter baumannii
- (2012) Benjamin A. Evans et al. CURRENT PHARMACEUTICAL DESIGN
- Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms
- (2012) Quan-Guo Zhang et al. Evolutionary Applications
- Evolutionary dynamics of separate and combined exposure ofPseudomonas fluorescensSBW25 to antibiotics and bacteriophage
- (2012) Patricia Escobar-Páramo et al. Evolutionary Applications
- Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies
- (2012) Y. Cai et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Isolation and Characterization of φkm18p, a Novel Lytic Phage with Therapeutic Potential against Extensively Drug Resistant Acinetobacter baumannii
- (2012) Gwan-Han Shen et al. PLoS One
- Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both Gram-positive and Gram-negative bacteria
- (2011) Meng-Jiun Lai et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Genomic analysis of bacteriophage ϕAB1, a ϕKMV-like virus infecting multidrug-resistant Acinetobacter baumannii
- (2011) Kai-Chih Chang et al. GENOMICS
- The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
- (2010) Josiane E. Garneau et al. NATURE
- Isolation and characterization of ϕAB2: a novel bacteriophage of Acinetobacter baumannii
- (2010) Nien-Tsung Lin et al. RESEARCH IN MICROBIOLOGY
- Bacteriophages as potential new therapeutics to replace or supplement antibiotics
- (2010) Mzia Kutateladze et al. TRENDS IN BIOTECHNOLOGY
- Multidrug-Resistant Enterococci Lack CRISPR-cas
- (2010) K. L. Palmer et al. mBio
- Multidrug Resistance in Bacteria
- (2009) Hiroshi Nikaido Annual Review of Biochemistry
- Global spread of carbapenem-resistant Acinetobacter baumannii
- (2009) P. G. Higgins et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials
- (2009) Maya Merabishvili et al. PLoS One
- Quantitative Models of In Vitro Bacteriophage–Host Dynamics and Their Application to Phage Therapy
- (2009) Benjamin J. Cairns et al. PLoS Pathogens
- Emergence and spread of carbapenem-resistant Acinetobacter baumannii in a tertiary care hospital in Turkey
- (2008) Meliha Meric et al. FEMS MICROBIOLOGY LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started